| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,504 | 4,534 | 20:30 | |
| 4,502 | 4,536 | 20:27 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 5,260 | 1.000 | |||
| 5,050 | 1.400 | |||
| 4,970 | 270 | |||
| 4,950 | 900 | |||
| 4,900 | 1.000 | |||
| 4,740 | 500 | |||
| 4,650 | 285 | |||
| 4,540 | 950 | |||
| 4,536 | 950 | |||
| 4,532 | 5.387 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/evt.htm [/URL] | ||||
| 1.777 | 4,502 | |||
| 2.000 | 4,480 | |||
| 3.610 | 4,474 | |||
| 950 | 4,470 | |||
| 950 | 4,466 | |||
| 393 | 4,450 | |||
| 1.211 | 4,440 | |||
| 750 | 4,420 | |||
| 1.200 | 4,410 | |||
| 600 | 4,400 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 13.441 | 0,941 | 12.642 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 17:29:45 | 4,498 | 224 |
| 17:29:45 | 4,498 | 46 |
| 17:29:45 | 4,496 | 229 |
| 17:29:28 | 4,492 | 646 |
| 17:29:28 | 4,498 | 238 |
| 17:29:28 | 4,496 | 22 |
| 17:29:11 | 4,494 | 252 |
| 17:28:34 | 4,490 | 230 |
| 17:27:41 | 4,494 | 5 |
| 17:27:30 | 4,486 | 1 |
| 17:27:25 | 4,486 | 100 |
| 17:27:09 | 4,490 | 21 |
| 17:26:29 | 4,490 | 238 |
| 17:24:42 | 4,494 | 299 |
| 17:24:22 | 4,490 | 324 |
| 17:24:13 | 4,488 | 58 |
| 17:24:03 | 4,488 | 257 |
| 17:23:41 | 4,488 | 227 |
| 17:23:38 | 4,488 | 73 |
| 17:23:38 | 4,488 | 612 |
| Tagesumsatz Xetra | +0,004 +0,09 % | 811.149 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| EVOTEC Aktie jetzt für 0€ handeln | |||||
| 16:38 | EVOTEC SE am Abend: Spannung trotz kleinem Rücksetzer! | 40 | Maximilian Berger | ||
| 16:30 | Evotec zieht durch: Warum erfahrene Anleger vor dem Wochenende zugreifen - Meine klare Einschätzung dazu | Hebelschein-Spekulant | |||
| 12:39 | Unlocking Massive Potential in Pharma's Largest Segment: Innovator Vidac Pharma, Industry Leader Bayer, or Turnaround Candidate Evotec? | 89 | The Market Herald Canada | ||
| 11:57 | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | 432 | EQS Group (EN) | EQS Voting Rights Announcement: Evotec SE
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| 11:51 | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | 418 | EQS Group (EN) | EQS Voting Rights Announcement: Evotec SE
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Do | Vanda Pharmaceuticals Inc.: Vanda Pharmaceuticals Calls on FDA to Withdraw Proposal from FY 2027 Legislative Agenda That Would Extend Drug Review Timelines | PR Newswire | WASHINGTON, April 9, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today highlighted a legislative proposal contained in the FDA's FY 2027... ► Artikel lesen | |
| Do | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 09.04.2026 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 09.04.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 09.04.2026ISIN NameCA29286M1059 ENGENE... ► Artikel lesen | |
| 16:18 | Weekly Buzz: MacroGenics Resumes LINNET; GSK Wins China Nod; FDA Okays Waters Corporation; Neurocrine Biosciences Snaps Up Soleno Therapeutics | AFX News | THOUSAND OAKS (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals across the U.S., Canada, and China, alongside the lifting of a clinical trial hold by the FDA, collaborations... ► Artikel lesen | |
| 07:10 | Idorsia Pharmaceuticals Ltd: Idorsia issues invitation to the 2026 Annual General Meeting of Shareholders | GlobeNewswire (Europe) | Allschwil, Switzerland - April 10, 2026Idorsia Ltd (SIX: IDIA) today issued the invitation to the upcoming Annual General Meeting (AGM) of Shareholders on behalf of the Board of Directors. The meeting... ► Artikel lesen | |
| Do | iSpecimen Inc.: iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time | Newsfile | Woburn, Massachusetts--(Newsfile Corp. - April 9, 2026) - iSpecimen (NASDAQ: ISPC), an online marketplace for human biospecimens, has implemented a streamlined shipping model that enables direct... ► Artikel lesen |